NCT06348849View on ClinicalTrials.gov

The Desensitising Effect of Nanosilver Fluoride in Molar-Incisor Hypomineralisation

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

June 1, 2024

Study Completion Date

August 1, 2024

Conditions
Molar Incisor HypomineralizationHypersensitivity
Interventions
DEVICE

Low-level laser therapy

Wavelength 980nm (SmartM, Lasotronix, Poland)

DRUG

Nanosilver fluoride

Optimized synthesis of Nanosilver Fluoride

Trial Locations (1)

21521

Faculty of Dentistry, Alexandria University, Alexandria

All Listed Sponsors
lead

Alexandria University

OTHER

NCT06348849 - The Desensitising Effect of Nanosilver Fluoride in Molar-Incisor Hypomineralisation | Biotech Hunter | Biotech Hunter